More opponents to BRCA-1

Several European research associations have joined efforts by the French Institute Curie to challenge the European BRCA-1 patent issued to Myriad Genetics Inc. (MYGN, Salt Lake City, Utah) (see BioCentury, Sept. 17).

A consortium including the Dutch Association of Molecular Genetics Laboratories; the Belgian Higher Council of Anthropogenetics; the Clinical Molecular Genetics Society of the U.K.; the Danish Society for Human Genetics; and the German Society for Human Genetics filed its own opposition to the patent with the European Patent Office...